© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Cholesterol-Lowering Treatment Is Associated With Improvement in Coronary Vascular Remodeling and Endothelial Function in Patients With Normal or Mildly Diseased Coronary Arteries
From the Center for Coronary Physiology and Imaging, The Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn.
Abstract— Coronary
vascular remodeling and altered endothelial function
have been described in the early stages of native
atherosclerosis. The purpose of this study was to
evaluate the association between cholesterol-lowering
therapy and coronary vascular remodeling and
endothelial function in patients with normal or mildly
diseases coronary arteries. Patients (N=101) with normal or
mildly diseased coronary arteries by coronary
angiography underwent intravascular ultrasound examination of the left
anterior descending coronary artery. Vessel and lumen area,
atherosclerotic plaque area, and plaque morphology were evaluated.
Vascular reactivity was examined with the use of intracoronary
adenosine, acetylcholine, and nitroglycerin.
Patients were divided into 3 groups based on the total
cholesterol levels: group 1 (n=25), patients with a history
of hypercholesterolemia adequately treated
(total cholesterol <240 mg/dL); group 2 (n=26), patients
with hypercholesterolemia not adequately
controlled (total cholesterol 
240 mg/dL); and group 3
(n=50), patients without hypercholesterolemia.
Vessel area and lumen area were significantly greater in groups 1 and 3
than in group 2 (for respective values in groups 1, 2, and 3: vessel
area 11.9±0.5, 10.6±0.4, and 11.8±0.4 mm2, both
P<0.05; lumen area 8.3±0.4, 6.9±0.3, and
8.9±0.3 mm2, both P<0.01). However,
plaque areas in groups 1 and 2 were similar. Furthermore,
acetylcholine-induced percent increases in coronary blood flow
were significantly greater in groups 1 and 3 than in group 2 (for
respective values in groups 1, 2, and 3: 70.5±20.1%, 22.8±13.7%,
and 68.6±14.8%, both P<0.05).
Cholesterol-lowering treatment is associated with an
improvement in coronary lumen area that results not from a
decrease in plaque area but from an increase in vessel area, reflecting
vascular remodeling. Additionally, this adaptive process may occur in
association with an improvement of
endothelium-dependent vasodilation of the resistance
coronary artery.
Key Words: remodeling • hypercholesterolemia • cholesterol • endothelium • ultrasonics
This article has been cited by other articles:
 |
|
 |
|
  S. Graf, A. Khorsand, M. Gwechenberger, C. Novotny, K. Kletter, H. Sochor, C. Pirich, G. Maurer, G. Porenta, and M. Zehetgruber Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk Factor Analysis Versus PET for Detection of Microvascular Disease J. Nucl. Med., February 1, 2007; 48(2): 175 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sipahi, E. M. Tuzcu, P. Schoenhagen, S. J. Nicholls, V. Ozduran, S. Kapadia, and S. E. Nissen Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial Eur. Heart J., July 2, 2006; 27(14): 1664 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Silver and J. A. Vita Shear Stress-Mediated Arterial Remodeling in Atherosclerosis: Too Much of a Good Thing? Circulation, June 20, 2006; 113(24): 2787 - 2789. [Full Text] [PDF]
|
|
|
|
|
|
A. A. Elesber, H. Solomon, R. J. Lennon, V. Mathew, A. Prasad, G. Pumper, R. E. Nelson, J. P. McConnell, L. O. Lerman, and A. Lerman Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis Eur. Heart J., April 1, 2006; 27(7): 824 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jimenez-Quevedo, M. Sabate, D. Angiolillo, F. Alfonso, R. Hernandez-Antolin, C. Banuelos, E. Bernardo, C. Ramirez, R. Moreno, C. Fernandez, et al. LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study Eur. Heart J., November 1, 2005; 26(21): 2307 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-A. Fassa, K. Wagatsuma, S. T. Higano, V. Mathew, G. W. Barsness, R. J. Lennon, D. R. Holmes Jr, and A. Lerman Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: A long-term follow-up study J. Am. Coll. Cardiol., January 18, 2005; 45(2): 204 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Biro, A. Masuda, T. Kihara, and C. Tei Clinical Implications of Thermal Therapy in Lifestyle-Related Diseases Experimental Biology and Medicine, November 1, 2003; 228(10): 1245 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Theilmeier, R. Quarck, P. Verhamme, M.-L. Bochaton-Piallat, M. Lox, H. Bernar, S. Janssens, M. Kockx, G. Gabbiani, D. Collen, et al. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty Cardiovasc Res, August 1, 2002; 55(2): 385 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Burke, F. D. Kolodgie, A. Farb, D. Weber, and R. Virmani Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis Circulation, January 22, 2002; 105(3): 297 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Malik, V. Melenovsky, D. Wichterle, T. Haas, J. Simek, R. Ceska, and J. Hradec Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial -- FAT) Cardiovasc Res, November 1, 2001; 52(2): 290 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weis, S. Pehlivanli, B. M. Meiser, and W. von Scheidt Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation J. Am. Coll. Cardiol., September 1, 2001; 38(3): 814 - 818. [Abstract] [Full Text] [PDF]
|
|